Neuroprotective effects of erythropoietin during deep hypothermic circulatory arrest

被引:11
作者
Givehchian, Mehdi [1 ]
Beschorner, Rudi [2 ]
Ehmann, Cornelius [1 ]
Frauenlob, Lydia [1 ]
Morgalla, Matthias [3 ]
Hashemi, Bahram [4 ]
Ziemer, Gerhard [1 ]
Scheule, Albertus M. [1 ]
机构
[1] Univ Tubingen, Dept Cardiac Thorac & Vasc Surg, Tubingen, Germany
[2] Univ Tubingen, Inst Brain Res, D-7400 Tubingen, Germany
[3] Univ Tubingen, Dept Neurosurg, Tubingen, Germany
[4] Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany
关键词
Hypothermic circulatory arrest; Cerebral ischaemia; Cardiopulmonary bypass; Erythropoietin; CENTRAL-NERVOUS-SYSTEM; NEURONAL APOPTOSIS; ACUTE STROKE; BRAIN; MICRODIALYSIS; TOLERANCE; ISCHEMIA; MARKER; MOUSE;
D O I
10.1016/j.ejcts.2009.07.048
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Permanent mild-to-severe brain injury with neurologic sequelae remains a significant source of postoperative morbidity in cardiovascular surgery. There is increasing evidence that erythropoietin confers neuroprotective effects in various conditions of neuronal damage, such as hypoxia and cerebral ischaemia. Using a surviving porcine model, this study evaluates whether systemic treatment with erythropoietin induces brain protection in deep hypothermic circulatory arrest (DHCA). Methods: Sixteen pigs (42 +/- 3 kg) randomly assigned into two groups (n = 8) were subjected to 60 min of DHCA at an intracerebral temperature of 20 degrees C. The animals of the erythropietin group were treated perioperatively with 500 IU kg(-1) of recombinant human erythropoietin on 3 consecutive days beginning the day before surgery. Intracerebral monitoring was performed by subcortical microdialysis, brain tissue oxygenation, measurement of brain temperature and intracranial pressure. Neurologic recovery was evaluated daily. Perioperative S100 beta protein serum level was determined. The brains were harvested on the postoperative day 6 after perfusion fixation. Multiple brain regions were investigated histologically for hypoxic-ischaemic damage. Results: The subcortical brain microdialysis detected significant increase of glycerol and lactate concentrations in both groups (P = 0.0001) with considerably higher concentrations in the brain of control animals (P = 0.011). There were no significant differences in neurological outcome (P = 0.15). Erythropoietin-treated animals tended to a more complete and rapid neurological recovery. By contrast, none of the animals in the control group achieved complete neurological recovery. S100 beta protein as a putative marker of cerebral injury tended to be higher in the control group. Brain infarction was detectable in all control animals but only in two erythropoietin-treated animals. Conclusion: These results suggest some beneficial neuroprotective effects of erythropoietin in this model of global brain ischaemia induced by 1 h of hypothermic circulatory arrest. (C) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:662 / 668
页数:7
相关论文
共 28 条
  • [1] The effect of cardiotomy suction on the brain injury marker S100β alter cardiopulmonary bypass
    Anderson, RE
    Hansson, LC
    Liska, J
    Settergren, G
    Vaage, J
    [J]. ANNALS OF THORACIC SURGERY, 2000, 69 (03) : 847 - 850
  • [2] Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury
    Brines, ML
    Ghezzi, P
    Keenan, S
    Agnello, D
    de Lanerolle, NC
    Cerami, C
    Itri, LM
    Cerami, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) : 10526 - 10531
  • [3] Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases
    Chong, ZZ
    Kang, JQ
    Maiese, K
    [J]. CIRCULATION, 2002, 106 (23) : 2973 - 2979
  • [4] Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades
    Chong, ZZ
    Kang, JQ
    Maiese, K
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2002, 22 (05) : 503 - 514
  • [5] Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades
    Digicaylioglu, M
    Lipton, SA
    [J]. NATURE, 2001, 412 (6847) : 641 - 647
  • [6] LOCALIZATION OF SPECIFIC ERYTHROPOIETIN BINDING-SITES IN DEFINED AREAS OF THE MOUSE-BRAIN
    DIGICAYLIOGLU, M
    BICHET, S
    MARTI, HH
    WENGER, RH
    RIVAS, LA
    BAUER, C
    GASSMANN, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) : 3717 - 3720
  • [7] Erythropoietin therapy for acute stroke is both safe and beneficial
    Ehrenreich, H
    Hasselblatt, M
    Dembowski, C
    Cepek, L
    Lewczuk, P
    Stiefel, M
    Rustenbeck, HH
    Breiter, N
    Jacob, S
    Knerlich, F
    Bohn, M
    Poser, W
    Rüther, E
    Kochen, M
    Gefeller, O
    Gleiter, C
    Wessel, TC
    De Ryck, M
    Itri, L
    Prange, H
    Cerami, A
    Brines, M
    Sirén, AL
    [J]. MOLECULAR MEDICINE, 2002, 8 (08) : 495 - 505
  • [8] Neurodevelopmental outcome after congenital heart surgery: Results from an institutional registry
    Forbess, JM
    Visconti, KJ
    Hancock-Friesen, C
    Howe, RC
    Bellinger, DC
    Jonas, RA
    [J]. CIRCULATION, 2002, 106 (13) : I95 - I102
  • [9] Increase of interstitial glycerol reflects the degree of ischaemic brain damage:: a PET and microdialysis study in a middle cerebral artery occlusion-reperfusion primate model
    Frykholm, P
    Hillered, L
    Långström, B
    Persson, L
    Valtysson, J
    Watanabe, Y
    Enblad, P
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 71 (04) : 455 - 461
  • [10] Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage
    Juul, S
    [J]. ACTA PAEDIATRICA, 2002, 91 : 36 - 42